Clamelle Chlamydia Test Kits sold in UK pharmacies
Actavis Group is pleased to announce that Clamelle Azithromycin 500mg Tablets and Clamelle Chlamydia Test Kits are now available for pharmacy distribution in the UK.
Clamelle Chlamydia Service
The Clamelle Chlamydia Service is a private service that is paid for by the consumer. It consists of the Clamelle Chlamydia Test Kit and Clamelle Azithromycin 500mg Tablets. The Clamelle test kit is purchased in a UK pharmacy, a urine sample posted off by the consumer to the laboratory and the result can be sent to the consumer by post or obtained from the pharmacy. If a confirmed positive test is received and if the treatment is deemed appropriate, following a sexual health consultation with the pharmacist, Clamelle Azithromycin 500mg Tablets can be supplied.
The Clamelle Chlamydia service is run jointly by Actavis, the NPA and Gordon Laboratory Group (GLG), a private laboratory which carries out the gold standard Nucleic Acid Amplification Technique (NAAT) testing, manages the test results and the Clamelle customer database.
Clamelle Chlamydia Test Kit and Tablets can only be sold by pharmacies that have registered with the NPA for the Clamelle Chlamydia service, obtained the NPA chlamydia resource pack and registered with GLG. Since the NPA launched the service three months ago, over 7,500 pharmacies have registered with the NPA and received the chlamydia resource pack.
The Actavis Clamelle training packs have now been distributed to all UK pharmacies. This comprehensive training has been developed with genitourinary medicine expert input, is accredited by the College of Pharmacy Practice and British Association of Sexual Health and HIV (BASHH) and has been awarded the NPA Training seal.
Extensive consumer research was conducted into the packaging for both the Clamelle Azithromycin 500mg Tablets and Test Kit. The resulting pack’s clean white background gives a medical, professional feel enhanced with the contemporary silver Clamelle logo. In response to consumer feedback the packs have been designed to appeal to both females and males, with striking pink and blue graphics.
A website www.clamelle.co.uk has been created to offer consumers information on chlamydia, about getting tested and treated, and a comprehensive FAQ section. The website also contains a Pharmacist section, which contains copies of all the Clamelle training materials for pharmacies to download.
Note to editors:
POM to P reclassification
The MHRA granted a pharmacy licence for azithromycin in August 2008. The reclassification of azithromycin differs from previous POM to P switches:
• Azithromycin is the first oral antibiotic switch
• The medicine treats a sexually transmitted infection – chlamydia is a significant communicable disease and is associated with significant complication, including fertility
• The switch is linked directly to a pharmacy professional service. This involves:
o An accredited laboratory test to confirm diagnosis
o Effective treatment
o One to one sexual health consultation
Clamelle Azithromycin 500mg Tablets and Clamelle Chlamydia Kit
Clamelle Azithromycin 500mg Tablets is a new Pharmacy-only antibiotic indicated for confirmed asymptomatic genital Chlamydia trachomatis infection and epidemiological treatment of their sexual partners. It may be given to men and women aged 16 years and over who have tested positive for chlamydia and can also be given to their sexual partners, without them needing to take a test.
The Clamelle Chlamydia Test diagnoses chlamydia using a laboratory Nucleic Acid Amplification Technique (NAAT) test, which detects the nucleic acid of the C. trachomatis bacterium. The NAAT test is the required gold standard test for detecting chlamydia infection in men and women.
- Contact Information
- Hjordis Arnadottir
- Director, External Communications
- Actavis Group
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.